Bupa completes sale of Bupa Home Healthcare to Celesio

01 July 2016

Bupa today announced the completion of the sale of Bupa Home Healthcare to Celesio. This follows approval from the Competition & Markets Authority in the UK, which was received on 28 June 2016.


Media: Bupa UK Press Office 020 7656 2454

Investors: Gareth Evans (Treasury) 020 7656 2316

About Bupa Home Healthcare

Bupa Home Healthcare is a leading provider of high quality home healthcare services supporting over 35,000 patients across the UK. It works in partnership with the NHS, pharmaceutical industry and private medical insurers to support patients with a range of conditions. Bupa Home Healthcare employs approximately 1000 people who work across the UK.

About Bupa

Bupa's purpose is helping people live longer, healthier, happier lives. Our status, as a company limited by guarantee with no shareholders, enables us to make our customers our focus, reinvesting our profits to provide more and better healthcare for current and future customers.

We employ over 84,000 people, principally in the UK, Australia, Spain, Poland, Hong Kong, Chile, Brazil, Saudi Arabia, India, New Zealand, Thailand and the US.

Around 70% of our revenue is from health insurance, with the rest from health and care provision. We fund healthcare around the world and run clinics, hospitals, dental centres, care homes and retirement villages in a number of countries.

For more information, visit www.bupa.com.

About Celesio

Celesio UK is a leading provider of integrated healthcare services to the NHS specialising in medicines, pharmaceutical care and primary care patient services. With almost 21,000 employees, more than 1,550 community pharmacies, a UK-wide logistics network and dispensing in excess of 150 million items a year, Celesio UK works in partnership with the NHS, community pharmacies and medicines manufacturers to help UK citizens live longer, healthier and more positive lives. Celesio provides customers, the NHS and patients with high levels of service, value, efficiency and innovation. Celesio UK comprises LloydsPharmacy, AAH Pharmaceuticals, Evolution Homecare, LloydsPharmacy Online Doctor and Betterlife. Celesio UK is part of Celesio Group; a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care. With some 39,000 employees, Celesio Group operates in 14 countries around the world. Every day, the group serves over 2 million customers – at about 2,200 pharmacies of its own and over 4,300 participants in brand partnership schemes. With 133 wholesale branches, Celesio supplies 65,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products. The services benefit a patient pool of about 15 million per day. McKesson Corporation, San Francisco, USA, is the majority shareholder in Celesio AG. The company acquired more than 75 percent of Celesio AG shares in February 2014. McKesson provides solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information visit www.celesio.co.uk and www.celesio.com

Share this

Contact Bupa Press Office

If you're a journalist and would like to find out more about any of our activity, or request a comment from one of our spokespeople, please contact the Bupa Press Office via one of the below